PubRank

S R Friedman

Author PubWeight™ 171.59‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. Lancet 1999 8.91
2 HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. JAMA 1989 6.68
3 HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet 1996 5.43
4 Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA 1995 4.88
5 Structural interventions: concepts, challenges and opportunities for research. J Urban Health 2006 4.70
6 Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS 1987 3.78
7 Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users. Ann Intern Med 1985 3.63
8 Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992. JAMA 1994 3.41
9 HIV infection among intravenous drug users: epidemiology and risk reduction. AIDS 1987 3.24
10 Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. Am J Public Health 1995 3.24
11 International epidemiology of HIV and AIDS among injecting drug users. AIDS 1992 3.19
12 Reducing the risk of AIDS through methadone maintenance treatment. J Health Soc Behav 1988 3.14
13 The relevance of drug injectors' social and risk networks for understanding and preventing HIV infection. Soc Sci Med 1994 3.05
14 AIDS health education for intravenous drug users. Health Educ Q 1986 2.92
15 HIV infection and intravenous drug use: critical issues in transmission dynamics, infection outcomes, and prevention. Rev Infect Dis 1988 2.91
16 HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemic. Am J Public Health 2000 2.74
17 AIDS and self-organization among intravenous drug users. Int J Addict 1987 2.73
18 High-risk personal networks and syringe sharing as risk factors for HIV infection among new drug injectors. J Acquir Immune Defic Syndr Hum Retrovirol 1996 2.38
19 Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996. Am J Public Health 1998 2.28
20 Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City. Am J Public Health 2001 2.21
21 A larger spectrum of severe HIV-1--related disease in intravenous drug users in New York City. Science 1988 2.20
22 Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors. Addiction 2001 2.17
23 Behavioral risk reduction in a declining HIV epidemic: injection drug users in New York City, 1990-1997. Am J Public Health 2000 2.09
24 Estimates of injecting drug users at the national and local level in developing and transitional countries, and gender and age distribution. Sex Transm Infect 2006 2.00
25 Syringe-mediated drug sharing among injecting drug users: patterns, social context and implications for transmission of blood-borne pathogens. Soc Sci Med 1996 1.93
26 Fifteen years of research on preventing HIV infection among injecting drug users: what we have learned, what we have not learned, what we have done, what we have not done. Public Health Rep 1998 1.92
27 Risk behavior and HIV infection among new drug injectors in the era of AIDS in New York City. J Acquir Immune Defic Syndr Hum Retrovirol 1999 1.87
28 Syringe-mediated drug-sharing (backloading): a new risk factor for HIV among injecting drug users. AIDS 1993 1.72
29 Regulating controversial programs for unpopular people: methadone maintenance and syringe exchange programs. Am J Public Health 1995 1.72
30 The epidemic of acquired immunodeficiency syndrome (AIDS) and suggestions for its control in drug abusers. J Subst Abuse Treat 1984 1.70
31 Geographic proximity, policy and utilization of syringe exchange programmes. AIDS Care 1999 1.70
32 Measuring the effects of an international health professions faculty development fellowship: the FAIMER Institute. Med Teach 2010 1.68
33 AIDS and the transition to illicit drug injection--results of a randomized trial prevention program. Br J Addict 1992 1.68
34 Stigmatized drug use, sexual partner concurrency, and other sex risk network and behavior characteristics of 18- to 24-year-old youth in a high-risk neighborhood. Sex Transm Dis 2001 1.62
35 Development of AIDS, HIV seroconversion, and potential co-factors for T4 cell loss in a cohort of intravenous drug users. AIDS 1987 1.60
36 Risk factors and HIV seropositivity among injecting drug users in Bangkok. AIDS 1991 1.60
37 Harm reduction: a public health response to the AIDS epidemic among injecting drug users. Annu Rev Public Health 1993 1.57
38 The protective effect of AIDS-related behavioral change among injection drug users: a cross-national study. WHO Multi-Centre Study of AIDS and Injecting Drug Use. Am J Public Health 1996 1.51
39 AIDS and i.v. drug use. Science 1989 1.51
40 Self-reports of HIV risk behavior by injecting drug users: are they reliable? Addiction 1995 1.49
41 Shooting galleries and AIDS: infection probabilities and 'tough' policies. Am J Public Health 1990 1.43
42 Using dyadic data for a network analysis of HIV infection and risk behaviors among injecting drug users. NIDA Res Monogr 1995 1.41
43 Effects of outreach intervention on risk reduction among intravenous drug users. AIDS Educ Prev 1990 1.37
44 Keeping it together: stigma, response, and perception of risk in relationships between drug injectors and crack smokers, and other community residents. AIDS Care 2005 1.37
45 Intravenous drug use and the heterosexual transmission of the human immunodeficiency virus. Current trends in New York City. N Y State J Med 1987 1.32
46 Implications of directly observed therapy in tuberculosis control measures among IDUs. Public Health Rep 1994 1.30
47 Working with heroin sniffers: clinical issues in preventing drug injection. J Subst Abuse Treat 1990 1.28
48 An interview study of participants in the Tacoma, Washington, syringe exchange. Addiction 1993 1.27
49 Cocaine injection and ethnicity in parenteral drug users during the early years of the human immunodeficiency virus (HIV) epidemic in New York City. J Med Virol 1989 1.27
50 HIV infection among persons who inject illicit drugs: problems and prospects. J Acquir Immune Defic Syndr 1988 1.25
51 Nonrandom development of immunologic abnormalities after infection with human immunodeficiency virus: implications for immunologic classification of the disease. Proc Natl Acad Sci U S A 1987 1.24
52 AIDS risk reduction and reduced HIV seroconversion among injection drug users in Bangkok. Am J Public Health 1994 1.21
53 HIV/AIDS-related behavior change among injecting drug users in different national settings. AIDS 1995 1.19
54 Sexual transmission risk among noninjecting heroin users infected with human immunodeficiency virus or hepatitis C virus. J Infect Dis 2001 1.14
55 Impact of a needle exchange program on potentially infectious syringes in public places. J Acquir Immune Defic Syndr 1992 1.08
56 Psychological and behavioral impact among intravenous drug users of learning HIV test results. Int J Addict 1990 1.08
57 AIDS and the use of injected drugs. Sci Am 1994 1.06
58 Knowledge about and behaviors affecting the spread of AIDS: a street survey of intravenous drug users and their associates in New York City. Int J Addict 1990 1.02
59 Street-recruited intravenous drug users and sexual risk reduction in New York City. AIDS 1990 1.02
60 HIV epidemiology and interventions among injecting drug users. Int J STD AIDS 1996 1.00
61 Condom use with primary partners among injecting drug users in Bangkok, Thailand and New York City, United States. AIDS 1993 0.99
62 Regulating syringe exchange programs: a cautionary note. JAMA 1994 0.96
63 Co-infection with malaria and HIV in injecting drug users in Brazil: a new challenge to public health? Addiction 1999 0.94
64 The Tacoma Syringe Exchange. J Addict Dis 1991 0.94
65 Heterosexual partners: a large risk group for AIDS. Lancet 1984 0.92
66 Implications of the revised surveillance definition: AIDS among New York City drug users. Am J Public Health 1992 0.92
67 Intravenous cocaine, crack, and HIV infection. JAMA 1988 0.90
68 STI/HIV Sexual Risk Behavior and Prevalent STI Among Incarcerated African American Men in Committed Partnerships: The Significance of Poverty, Mood Disorders, and Substance Use. AIDS Behav 2015 0.90
69 Crack cocaine use in a cohort of methadone maintenance patients. J Subst Abuse Treat 1992 0.89
70 HIV testing and sexual behavior among intravenous drug users in Bangkok, Thailand. J Acquir Immune Defic Syndr 1992 0.89
71 Syringe exchange: HIV prevention, key findings, and future directions. Int J Addict 1995 0.89
72 Injection drug users as social actors: a stigmatized community's participation in the syringe exchange programmes of New York City. AIDS Care 1998 0.88
73 Organizing as a new approach to AIDS risk reduction for intravenous drug users. J Addict Dis 1991 0.88
74 A multicentre study on the causes of death among Italian injecting drug users. AIDS has overtaken overdose as the principal cause of death. AIDS Care 1998 0.87
75 Declines in proportion of Kaposi's sarcoma among cases of AIDS in multiple risk groups in New York City. Lancet 1987 0.87
76 Critical issues regarding AIDS among injecting drug users. Bull Narc 1993 0.86
77 Continued risky injection subsequent to syringe exchange use among injection drug users in New York City. AIDS Educ Prev 1997 0.85
78 Will bleach decontaminate needles during cocaine binges in shooting galleries? JAMA 1989 0.85
79 HIV and intravenous drug use. AIDS 1988 0.85
80 Injection drug use and emerging blood-borne diseases. JAMA 1996 0.85
81 Residential status and HIV risk behaviors among Puerto Rican drug injectors in New York and Puerto Rico. Am J Drug Alcohol Abuse 2001 0.84
82 "Why I am not infected with HIV": implications for long-term HIV risk reduction and HIV vaccine trials. J Acquir Immune Defic Syndr Hum Retrovirol 1997 0.84
83 Executive functioning in adult attention-deficit hyperactivity disorder. Clin Neuropsychol 2001 0.84
84 The sharing of drug injection equipment and the AIDS epidemic in New York City: the first decade. NIDA Res Monogr 1988 0.83
85 Specificity of antibody tests for human immunodeficiency virus in alcohol and parenteral drug abusers with chronic liver disease. Alcohol Clin Exp Res 1988 0.83
86 The incidence of HBV infection and syringe exchange programs. JAMA 1991 0.83
87 A stage model of HTLV-III LAV infection in intravenous drug users. NIDA Res Monogr 1986 0.81
88 Risk factors for HIV-1 seroprevalence among drug injectors in the cocaine-using environment of Rio de Janeiro. Addiction 1994 0.81
89 A new approach to prevent HIV transmission: Project Protect intervention for recently infected individuals. AIDS Care 2014 0.81
90 Hepatitis C transmission and the underreporting of stigmatized behaviors. Sex Transm Dis 1998 0.80
91 Needle sharing among IVDUs at risk for AIDS. Am J Public Health 1988 0.79
92 The message not heard: myth and reality in discussions about syringe exchange. AIDS 1999 0.78
93 From ideology to logistics: the organizational aspects of syringe exchange in a period of institutional consolidation. Subst Use Misuse 1998 0.78
94 The transition from underground to legal syringe exchange: the New York City experience. AIDS Educ Prev 1996 0.77
95 Public awareness of AIDS in Rwanda. Soc Sci Med 1987 0.77
96 Therapeutic ethics and communities at risk in the presence of potential mutation to resistant strains to HIV antiviral medications. AIDS 1998 0.76
97 History, biography, and HIV infection. Am J Public Health 1992 0.75
98 Re: "The harm reduction approach and risk factors for human immunodeficiency virus (HIV) seroconversion in injecting drug users, Amsterdam". Am J Epidemiol 1993 0.75
99 Network methodologies, contact tracing, gonorrhea, and human immunodeficiency virus. Sex Transm Dis 1997 0.75
100 Neuropathy: mono- or poly-? N Engl J Med 1970 0.75
101 CD4 lymphocytopenia among injecting drug users in New York City. J Acquir Immune Defic Syndr 1993 0.75
102 HIV infection and AIDS among drug injectors at Rio de Janeiro: perspectives and unanswered questions. Bull Narc 1993 0.75
103 Drug legalization, harm reduction, and drug policy. Ann Intern Med 1996 0.75
104 Cocaine, AIDS and i.v. drug use. J Addict Dis 1991 0.75
105 Gender differences in response to HIV infection. Adv Biochem Psychopharmacol 1988 0.75
106 Drug use. Vancouver Conference Review. AIDS Care 1997 0.75